Analysis and rationality evaluation of the application of nirmatrelvir tablets/ritonavir tablets (co-packaged) in patients with COVID-19

LIU Xiao-lin; LU Xiao-xiao; QU Dan; GONG Jing-ru; LU Hui-ping

doi:10.3969/j.issn.1672-8157.2022.05.014

Home>Articles>Analysis and rationality evaluation of the application of nirmatrelvir tablets/ritonavir tablets (co-packaged) in patients with COVID-19

DOI: 10.3969/j.issn.1672-8157.2022.05.014

Analysis and rationality evaluation of the application of nirmatrelvir tablets/ritonavir tablets (co-packaged) in patients with COVID-19

LIU Xiao-lin

LU Xiao-xiao

QU Dan

GONG Jing-ru

LU Hui-ping

Machine-generated Keywords：

Publication Date：2022-10-25

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 331-334 )

Chinese Journal of Drug Application and Monitoring

ISTIC

ISSN：1672-8157

Year, Vol.(Issue)：2022,19(5)